DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,987 | +0.6% | 32,192 | -2.7% | 0.03% | -6.2% |
Q2 2023 | $7,938 | -5.7% | 33,077 | -1.0% | 0.03% | -15.8% |
Q1 2023 | $8,418 | -33.6% | 33,400 | -30.1% | 0.04% | -40.6% |
Q4 2022 | $12,682 | -99.9% | 47,780 | -32.2% | 0.06% | -40.7% |
Q3 2022 | $18,209,000 | -13.3% | 70,499 | -14.9% | 0.11% | -16.3% |
Q2 2022 | $21,010,000 | -9.2% | 82,870 | +5.0% | 0.13% | -5.1% |
Q1 2022 | $23,148,000 | -21.1% | 78,915 | -11.5% | 0.14% | -24.9% |
Q4 2021 | $29,349,000 | +16.1% | 89,205 | +7.5% | 0.18% | +2.3% |
Q3 2021 | $25,269,000 | +21.6% | 83,000 | +7.2% | 0.18% | +10.6% |
Q2 2021 | $20,780,000 | +14.1% | 77,434 | -4.3% | 0.16% | -3.6% |
Q1 2021 | $18,207,000 | +20.3% | 80,892 | +18.7% | 0.17% | -12.2% |
Q4 2020 | $15,133,000 | +8.9% | 68,123 | +5.6% | 0.19% | -9.6% |
Q3 2020 | $13,894,000 | +31.8% | 64,522 | +8.2% | 0.21% | +9.4% |
Q2 2020 | $10,541,000 | +22.7% | 59,611 | -3.9% | 0.19% | +1.1% |
Q1 2020 | $8,589,000 | -12.5% | 62,055 | -3.0% | 0.19% | -3.6% |
Q4 2019 | $9,817,000 | +22.1% | 63,961 | +14.9% | 0.20% | +3.7% |
Q3 2019 | $8,042,000 | +17.6% | 55,681 | +16.3% | 0.19% | +4.4% |
Q2 2019 | $6,841,000 | -38.0% | 47,863 | -49.4% | 0.18% | -23.6% |
Q1 2019 | $11,038,000 | – | 94,578 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |